JHS Svendgaard Laboratories' Q1 FY 2026-27 Quarterly Results
- 12 Aug 2026
Result Summary
- JHS Svendgaard Laboratories Ltd reported a 8.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 24.6%.
- Its expenses for the quarter were down by 16.5% QoQ and up 27.6% YoY.
- The net profit decreased 130.5% QoQ and increased 2.8% YoY.
- The earnings per share (EPS) of JHS Svendgaard Laboratories Ltd stood at 0.12 during Q1 FY 2026-27.
Financial Statments for Q1 FY 2026-27
(₹ crores) | Q1FY27 | Q4FY26 | Q1FY26 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 30.47 | 33.42 | 24.45 | -8.8% | 24.6% |
Total Expenses | 30.41 | 36.40 | 23.83 | -16.5% | 27.6% |
Profit Before Tax | 0.06 | -2.98 | 0.63 | -102.0% | -90.5% |
Tax | -1.03 | 0.59 | -0.43 | -274.6% | 139.5% |
Profit After Tax | 1.09 | -3.57 | 1.06 | -130.5% | 2.8% |
Earnings Per Share | 0.12 | -0.42 | 0.12 | -128.6% | 0.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
JHS Svendgaard Laboratories Ltd is a company that operates primarily in the oral care industry. It is known for manufacturing and marketing a variety of dental and oral hygiene products. The company's product portfolio includes toothbrushes, toothpastes, and other related oral care products. The company is engaged in both domestic and international markets, catering to a diverse range of consumers. As of the data available up to October 2023, there are no recent major developments or changes in the company's strategic direction that have been publicly disclosed.
Revenue
In the first quarter of the fiscal year 2027 (Q1FY27), JHS Svendgaard Laboratories Ltd reported total income of ₹30.47 crores. This represents a decrease of 8.8% compared to the previous quarter (Q4FY26), where total income was ₹33.42 crores. However, when compared to the same quarter in the previous year (Q1FY26), total income shows a growth of 24.6%, rising from ₹24.45 crores. This year-over-year increase indicates a positive change in revenue generation over the twelve-month period.
Profitability
For Q1FY27, JHS Svendgaard Laboratories Ltd recorded a profit before tax of ₹0.06 crores, which contrasts with a loss before tax of ₹2.98 crores in Q4FY26. When compared to Q1FY26, the profit before tax has decreased from ₹0.63 crores. The profit after tax for the current quarter is ₹1.09 crores, showing a significant improvement from a loss after tax of ₹3.57 crores in the previous quarter. The profit after tax in Q1FY26 was ₹1.06 crores, indicating a slight year-over-year increase of 2.8%. Earnings per share for Q1FY27 stand at ₹0.12, consistent with the same quarter of the previous year, and an improvement from a negative earnings per share of ₹-0.42 in Q4FY26.
Operating Metrics
The company's total expenses in Q1FY27 were ₹30.41 crores, showing a reduction of 16.5% from the previous quarter, where expenses were ₹36.40 crores. This is an increase from the same period last year (Q1FY26), where expenses were ₹23.83 crores, representing a 27.6% rise. The tax expense for Q1FY27 was reported as a negative ₹1.03 crores, compared to a positive tax expense of ₹0.59 crores in Q4FY26 and a negative tax of ₹0.43 crores in Q1FY26. These figures suggest a fluctuation in tax expenses over the quarters. The financial data presented does not include specific details necessary to calculate other key financial ratios such as the P/E ratio, debt-to-equity ratio, or current ratio.
FAQs
JHS Svendgaard Laboratories Ltd announced its Q1 FY 2026-27 results on 12 August, 2026.
JHS Svendgaard Laboratories Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of JHS Svendgaard Laboratories Ltd Q1 FY 2026-27 results include:
- Revenue: ₹30.47 crore
- Net Profit: ₹1.09 crore
- EBITDA: ₹2.16 crore
- Year-over-Year Growth: 24.6%
- Quarter-over-Quarter Growth: -8.8%
JHS Svendgaard Laboratories Ltd reported a net loss of ₹1.09 crore in Q1 FY 2026-27, reflecting a 2.8% year-over-year growth.
JHS Svendgaard Laboratories Ltd posted a revenue of ₹30.47 crore in Q1 FY 2026-27.